NFKB1: The Protein Responsible for Many Body Functions (G4790)

Target Name: NFKB1

NCBI ID: G4790

NFKB1: The Protein Responsible for Many Body Functions

The nervous system is a complex and intricate system that is responsible for the majority of our bodily functions. It is made up of a vast array of neurons and synapses, and is responsible for transmitting and processing information that is crucial for our survival. One of the key proteins that is involved in this process is NFKB1 (N-linked K-V transmembrane protein 1).

NFKB1 is a protein that is expressed in many different tissues throughout the body, including the brain, spinal cord, and heart. It is a member of the family of transcription factors, which are proteins that regulate the expression of genes. NFKB1 is involved in the regulation of a wide range of gene expression, including the expression of genes that are involved in the immune response, inflammation, and cell survival.

One of the key functions of NFKB1 is its role in the regulation of inflammation. In response to the release of stress hormones, NFKB1 is involved in the production of pro-inflammatory cytokines, which help to recruit immune cells to the site of injury or infection . This is important for the initial response to an infection, as it allows the body to begin to fight back against the invading microorganisms.

Another important function of NFKB1 is its role in the regulation of cell death. NFKB1 is involved in the production of pro-apoptotic cytokines, which are proteins that cause cells to self-destruct. This is important for the regulation of cell life cycle, as it helps to ensure that cells are properly disposed of and that new cells are created only when needed.

In addition to its role in inflammation and cell death, NFKB1 is also involved in the regulation of a wide range of other physiological processes. For example, it is involved in the regulation of blood pressure, and is thought to play a role in the development of hypertension. It is also involved in the regulation of bone density, and is thought to contribute to the development of osteoporosis.

Given its involvement in a wide range of important physiological processes, it is not surprising that NFKB1 has been identified as a potential drug target. Many studies have suggested that inhibiting the activity of NFKB1 may have a variety of potential therapeutic benefits, including the treatment of a wide range of diseases. For example, NFKB1 has been suggested as a potential treatment for a variety of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression.

In addition to its potential therapeutic applications, NFKB1 is also an important biomarker for a variety of diseases. For example, the levels of NFKB1 have been suggested as a potential diagnostic biomarker for a variety of diseases, including cancer. This is because the activity of NFKB1 is often altered in response to the presence of certain diseases, and the levels of this protein can be used as a diagnostic indicator.

Overall, NFKB1 is a complex and important protein that is involved in a wide range of physiological processes. Its potential as a drug target and biomarker make it an attractive target for further research and development. Further studies are needed to fully understand the role of NFKB1 in the regulation of the nervous system, and to determine the best way to use this protein as a therapeutic tool.

Protein Name: Nuclear Factor Kappa B Subunit 1

Functions: NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and RelB-p50 complexes are transcriptional activators. The NF-kappa-B p50-p50 homodimer is a transcriptional repressor, but can act as a transcriptional activator when associated with BCL3. NFKB1 appears to have dual functions such as cytoplasmic retention of attached NF-kappa-B proteins by p105 and generation of p50 by a cotranslational processing. The proteasome-mediated process ensures the production of both p50 and p105 and preserves their independent function, although processing of NFKB1/p105 also appears to occur post-translationally. p50 binds to the kappa-B consensus sequence 5'-GGRNNYYCC-3', located in the enhancer region of genes involved in immune response and acute phase reactions. In a complex with MAP3K8, NFKB1/p105 represses MAP3K8-induced MAPK signaling; active MAP3K8 is released by proteasome-dependent degradation of NFKB1/p105

More Common Targets